A detailed history of National Bank Of Canada transactions in Incyte Corp stock. As of the latest transaction made, National Bank Of Canada holds 81,728 shares of INCY stock, worth $6.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
81,728
Previous 81,728 -0.0%
Holding current value
$6.06 Million
Previous $5.4 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$57.33 - $68.61 $2.17 Million - $2.59 Million
37,809 Added 86.09%
81,728 $5.4 Million
Q2 2024

Aug 02, 2024

BUY
$51.18 - $63.75 $144,839 - $180,412
2,830 Added 6.89%
43,919 $2.66 Million
Q1 2024

May 13, 2024

SELL
$56.55 - $66.59 $130,347 - $153,489
-2,305 Reduced 5.31%
41,089 $2.34 Million
Q4 2023

Feb 06, 2024

SELL
$52.16 - $64.19 $4.42 Million - $5.44 Million
-84,795 Reduced 66.15%
43,394 $2.72 Million
Q3 2023

Oct 10, 2023

BUY
$57.77 - $65.93 $2.63 Million - $3 Million
45,484 Added 55.0%
128,189 $7.41 Million
Q2 2023

Jul 26, 2023

BUY
$60.95 - $75.51 $1.09 Million - $1.35 Million
17,865 Added 27.55%
82,705 $5.15 Million
Q1 2023

Apr 12, 2023

SELL
$70.23 - $86.01 $3.36 Million - $4.12 Million
-47,901 Reduced 42.49%
64,840 $4.69 Million
Q4 2022

Jan 24, 2023

BUY
$67.18 - $84.11 $5.96 Million - $7.46 Million
88,661 Added 368.19%
112,741 $0
Q3 2022

Oct 13, 2022

SELL
$66.18 - $82.86 $2.17 Million - $2.72 Million
-32,832 Reduced 57.69%
24,080 $1.66 Million
Q2 2022

Jul 28, 2022

BUY
$66.18 - $83.18 $1.89 Million - $2.38 Million
28,554 Added 100.69%
56,912 $4.42 Million
Q1 2022

May 05, 2022

BUY
$66.02 - $79.71 $1.83 Million - $2.21 Million
27,763 Added 4666.05%
28,358 $2.23 Million
Q4 2021

Jan 24, 2022

BUY
$63.34 - $74.11 $37,687 - $44,095
595 New
595 $44,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.